Another study found increased CD4+ memory activated T cells in T1-2 tumors compared to T3-4, as well as in tumor involved tissue compared to uninvolved tissue (9); however, this study did not assess for sex-related TME differences in CRC. This evidence concerns the gene CD4 and colorectal carcinoma.